On August 4, 2011, the third protocol amendment for our ongoing U.S. study of MDMA-assisted psychotherapy for veterans with PTSD was submitted to the FDA.
On August 4, 2011, the third protocol amendment for our ongoing U.S. study of MDMA-assisted psychotherapy for veterans with PTSD was submitted to the FDA.